Study: Despite increased resources, US lags in health outcomes
A study in JAMA reports that despite increased resources for health care, the US lags behind other peer nations in many areas, including life…
Web Exclusives
Study: Decreased sepsis mortality
A study published by Critical Care Medicine reports that in-hospital mortality rates for sepsis decreased from 47% between 1991 and 1995 to 29% between…
Study: Cooling temperature for therapeutic hypothermia
In unconscious patients who survived an out-of-hospital cardiac arrest, cooling to 33 degrees C was no more beneficial than 36 degrees C, according to…
Lowering BP prevents cardiovascular events in people with kidney disease
Lowering blood pressure (BP) is a highly effective and affordable way to prevent cardiovascular events like heart attack and stroke among people with chronic…
Vagus nerve stimulation may reduce HF symptoms
A global, multicenter randomized clinical trial called INOVATE-HF (INcrease Of VAgal TonE in chronic Heart Failure) is investigating the safety and efficacy of an…
Four new guidelines from AHA, ACC
The American Heart Association and the American College of Cardiology have released four guidelines related to preventing cardiovascular disease: cholesterol, obesity, lifestyle, assessment of…
Recall of MedStream Programmable Infusion Pump and Refill Kits
On Oct. 23, the U.S. Food and Drug Administration (FDA) noted that Codman & Shrutleff, Inc., has recalled its MedStream Programmable Pump and MedStream…
FDA approved Adempas for pulmonary hypertension
On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. Read more.
Recall of metoclopramide and ondansetron injections
On Oct. 2, the U.S. Food and Drug Administration (FDA) noted that Hospira has recalled one lot of metoclopramide injection and two lost of…
FDA approves Brintellix for major depression
On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Brintellix (vortioxetine) to treat adults with major depressive disorder. Read more.
FDA expands access to artificial heart valve to inoperable patients
On Sept. 23, the U.S. Food and Drug Administration (FDA) approved revised labeling for the Sapien Transcatheter Heart Valve (THV), making the device available…
FDA approves Liposorber Apheresis System for pediatric use
On Oct. 10, the U.S. Food and Drug Administration (FDA) approved Liposorber LA-15 System to treat pediatric patients with primary focal segmental glomerulosclerosis (FSGS)…
Study: Despite increased resources, US lags in health outcomes
A study in JAMA reports that despite increased resources for health care, the US lags behind other peer nations in many areas,…
Study: Decreased sepsis mortality
A study published by Critical Care Medicine reports that in-hospital mortality rates for sepsis decreased from 47% between 1991 and 1995 to…
Study: Cooling temperature for therapeutic hypothermia
In unconscious patients who survived an out-of-hospital cardiac arrest, cooling to 33 degrees C was no more beneficial than 36 degrees C,…
Lowering BP prevents cardiovascular events in people with kidney disease
Lowering blood pressure (BP) is a highly effective and affordable way to prevent cardiovascular events like heart attack and stroke among people…
Vagus nerve stimulation may reduce HF symptoms
A global, multicenter randomized clinical trial called INOVATE-HF (INcrease Of VAgal TonE in chronic Heart Failure) is investigating the safety and efficacy…
Four new guidelines from AHA, ACC
The American Heart Association and the American College of Cardiology have released four guidelines related to preventing cardiovascular disease: cholesterol, obesity, lifestyle,…
Recall of MedStream Programmable Infusion Pump and Refill Kits
On Oct. 23, the U.S. Food and Drug Administration (FDA) noted that Codman & Shrutleff, Inc., has recalled its MedStream Programmable Pump…
FDA approved Adempas for pulmonary hypertension
On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension.…
Recall of metoclopramide and ondansetron injections
On Oct. 2, the U.S. Food and Drug Administration (FDA) noted that Hospira has recalled one lot of metoclopramide injection and two…
FDA approves Brintellix for major depression
On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Brintellix (vortioxetine) to treat adults with major depressive disorder. Read more.
FDA expands access to artificial heart valve to inoperable patients
On Sept. 23, the U.S. Food and Drug Administration (FDA) approved revised labeling for the Sapien Transcatheter Heart Valve (THV), making the…
FDA approves Liposorber Apheresis System for pediatric use
On Oct. 10, the U.S. Food and Drug Administration (FDA) approved Liposorber LA-15 System to treat pediatric patients with primary focal segmental…
Test Your Knowledge
Cannabis TYK
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.